Facebook Linkedin RSS Twitter Youtube
Home 2024

Cell therapy

Cellular Origins Acquires ACTIA Platform IP for Cell Therapy Manufacturing
Bioprocessing

Cellular Origins Acquires ACTIA Platform IP for Cell Therapy Manufacturing

A Solution to Industry’s Lentiviral Vector Challenge?
Bioprocessing

A Solution to Industry’s Lentiviral Vector Challenge?

Unlocking Cell Therapy’s Full Potential by Rewiring T-Cell Metabolism
Insights

Unlocking Cell Therapy’s Full Potential by Rewiring T-Cell Metabolism

Standardized Cell and Gene Therapy Hub A Call to Action
Bioprocessing

Standardized Cell and Gene Therapy Hub A Call to Action

A New Research Toolbox at the Forefront of Genomic Engineering
Genome Editing

A New Research Toolbox at the Forefront of Genomic Engineering

Creating Consistency and Confidence for Biopharma Companies
Bioprocessing

Creating Consistency and Confidence for Biopharma Companies

Webinar Recap: Modeling the Holistic Journey of Solid Tumor Cell Therapy with Organ-Chips
Cancer

Webinar Recap: Modeling the Holistic Journey of Solid Tumor Cell Therapy with Organ-Chips

Overcoming Viral Vector Risks
Bioprocessing

Overcoming Viral Vector Risks

“Talent, Talent, Talent” Drives Fujifilm Diosynth’s $3.2B NC Expansion
Bioprocessing

“Talent, Talent, Talent” Drives Fujifilm Diosynth’s $3.2B NC Expansion

CAR T-Cell Therapy Gets Second Wind after Biomaterials Put Skin in the Game
Cancer

CAR T-Cell Therapy Gets Second Wind after Biomaterials Put Skin in the Game

123...105Page 1 of 105

Recently Featured

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.